Literature DB >> 17168734

The multifaceted roles of osteopontin in cell signaling, tumor progression and angiogenesis.

Goutam Chakraborty1, Shalini Jain, Reeti Behera, Mansoor Ahmed, Priyanka Sharma, Vinit Kumar, Gopal C Kundu.   

Abstract

Osteopontin (OPN) is a chemokine like phosphorylated glycoprotein that plays important role in cancer progression. Extensive research from various laboratories has demonstrated the likely role of OPN in regulating the cell signaling that ultimately controls tumor growth and metastasis. Several earlier reports indicated that OPN is associated with various cancers; but its functional role in carcinogenesis is still not well defined. Besides the role of OPN in tumor biology, several studies have demonstrated the pathophysiological role of OPN in diverse biological events. This review will focus on recent advances in understanding the molecular mechanism by which OPN regulates a series of signaling cascades through activation of various kinases and transcription factors that ultimately control the expression of downstream effector genes, which contribute to tumor progression and angiogenesis in vitro and animal models. We will also provide evidences that suggest the enhanced expression of OPN is not only associated with several tumor types, but its level of expression is directly correlated to various stages of the clinical specimens of breast and prostate cancers. These studies may be useful for identifying novel OPN-based therapeutic approach for the treatment of cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17168734     DOI: 10.2174/156652406779010803

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  42 in total

1.  DNAJB6 chaperones PP2A mediated dephosphorylation of GSK3β to downregulate β-catenin transcription target, osteopontin.

Authors:  A Mitra; M E Menezes; L K Pannell; M S Mulekar; R E Honkanen; L A Shevde; R S Samant
Journal:  Oncogene       Date:  2012-01-23       Impact factor: 9.867

2.  On the cutting edge of proprotein convertase pharmacology: from molecular concepts to clinical applications.

Authors:  Frédéric Couture; François D'Anjou; Robert Day
Journal:  Biomol Concepts       Date:  2011-10-01

3.  Identification of osteopontin as the most consistently over-expressed gene in intrahepatic cholangiocarcinoma: detection by oligonucleotide microarray and real-time PCR analysis.

Authors:  Holger G Hass; Oliver Nehls; Juergen Jobst; Andrea Frilling; Ulrich Vogel; Stephan Kaiser
Journal:  World J Gastroenterol       Date:  2008-04-28       Impact factor: 5.742

Review 4.  Prognostic significance of osteopontin in patients with lung cancer: a meta-analysis.

Authors:  Bin Peng; Yi-Han Wang; Zhuo Huang; Shi-Jian Feng; Yong-Sheng Wang
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 5.  Comparative analysis of gene expression profiles of OPN signaling pathway in four kinds of liver diseases.

Authors:  Gaiping Wang; Shasha Chen; Congcong Zhao; Xiaofang Li; Weiming Zhao; Jing Yang; Cuifang Chang; Cunshuan Xu
Journal:  J Genet       Date:  2016-09       Impact factor: 1.166

6.  Can combination of osteopontin and peritumor-infiltrating macrophages be a prognostic marker of early-stage hepatocellular carcinoma?

Authors:  Yoo Jin Lee; Byoung Kuk Jang
Journal:  Hepatobiliary Surg Nutr       Date:  2014-04       Impact factor: 7.293

7.  Osteopontin is not critical for otoconia formation or balance function.

Authors:  Xing Zhao; Sherri M Jones; Wallace B Thoreson; Yunxia Wang Lundberg
Journal:  J Assoc Res Otolaryngol       Date:  2008-05-06

8.  Osteopontin selectively regulates p70S6K/mTOR phosphorylation leading to NF-kappaB dependent AP-1-mediated ICAM-1 expression in breast cancer cells.

Authors:  Mansoor Ahmed; Gopal C Kundu
Journal:  Mol Cancer       Date:  2010-05-07       Impact factor: 27.401

9.  Gram-positive pathogenic bacteria induce a common early response in human monocytes.

Authors:  Svetlin Tchatalbachev; Rohit Ghai; Hamid Hossain; Trinad Chakraborty
Journal:  BMC Microbiol       Date:  2010-11-02       Impact factor: 3.605

10.  Transcriptional regulation of human osteopontin promoter by histone deacetylase inhibitor, trichostatin A in cervical cancer cells.

Authors:  Priyanka Sharma; Santosh Kumar; Gopal C Kundu
Journal:  Mol Cancer       Date:  2010-07-07       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.